Skip to main content
Journal cover image

Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.

Publication ,  Journal Article
Hermansen, K; Kolotkin, RL; Hammer, M; Zdravkovic, M; Matthews, D
Published in: Prim Care Diabetes
July 2010

Patient-reported outcomes for liraglutide or glimepiride on metformin were investigated. Patients' treatment satisfaction on liraglutide was higher than with metformin alone and comparable with glimepiride+metformin. Patients perceived lower frequency of hypoglycaemia than glimepiride+metformin and lower frequency of hyperglycaemia than metformin. Impact of weight on quality of life did not differ.

Duke Scholars

Published In

Prim Care Diabetes

DOI

EISSN

1878-0210

Publication Date

July 2010

Volume

4

Issue

2

Start / End Page

113 / 117

Location

England

Related Subject Headings

  • Treatment Outcome
  • Sulfonylurea Compounds
  • Quality of Life
  • Patient Satisfaction
  • Middle Aged
  • Metformin
  • Male
  • Liraglutide
  • Hypoglycemic Agents
  • Hypoglycemia
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hermansen, K., Kolotkin, R. L., Hammer, M., Zdravkovic, M., & Matthews, D. (2010). Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Prim Care Diabetes, 4(2), 113–117. https://doi.org/10.1016/j.pcd.2010.04.001
Hermansen, Kjeld, Ronette L. Kolotkin, Mette Hammer, Milan Zdravkovic, and David Matthews. “Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.Prim Care Diabetes 4, no. 2 (July 2010): 113–17. https://doi.org/10.1016/j.pcd.2010.04.001.
Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Prim Care Diabetes. 2010 Jul;4(2):113–7.
Hermansen, Kjeld, et al. “Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.Prim Care Diabetes, vol. 4, no. 2, July 2010, pp. 113–17. Pubmed, doi:10.1016/j.pcd.2010.04.001.
Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Prim Care Diabetes. 2010 Jul;4(2):113–117.
Journal cover image

Published In

Prim Care Diabetes

DOI

EISSN

1878-0210

Publication Date

July 2010

Volume

4

Issue

2

Start / End Page

113 / 117

Location

England

Related Subject Headings

  • Treatment Outcome
  • Sulfonylurea Compounds
  • Quality of Life
  • Patient Satisfaction
  • Middle Aged
  • Metformin
  • Male
  • Liraglutide
  • Hypoglycemic Agents
  • Hypoglycemia